On January 16, 2009 NOF and the New Mexico Healthy Aging Collaborative hosted a Strong Voices for Strong Bones Advocacy Training Meeting in Albuquerque, New Mexico. At this workshop, attendees from around the state learned about advocating for better bone health and osteoporosis prevention and treatment with local, state and federal government officials. The meeting was well attended by health professionals; community leaders working with families and the elderly and Native American populations across the state; local and state government staff who work on public health, wellness and aging issues; and people with or at risk of osteoporosis and their families.
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.